Stroke in users of low-dose oral contraceptives

被引:260
作者
Petitti, DB
Sidney, S
Bernstein, A
Wolf, S
Quesenberry, C
Ziel, HK
机构
[1] KAISER PERMANENTE MED CARE PROGRAM,PASADENA,CA
[2] KAISER PERMANENTE MED CARE PROGRAM,OAKLAND,CA
关键词
D O I
10.1056/NEJM199607043350102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Previous studies have linked the use of oral contraceptive agents to an increased risk of stroke, but those studies have been limited to oral contraceptives containing more estrogen than is now generally used. Methods In a population-based, case-control study, we identified fatal and nonfatal strokes in female members of the California Kaiser Permanente Medical Care Program who were 15 through 44 years of age. Matched controls were randomly selected from female members who had not had strokes. Information about the use of oral contraceptives (essentially limited to low-estrogen preparations) was obtained in interviews. Results-A total of 408 confirmed strokes occurred in a total of 1.1 million women during 3.6 million woman-years of observation. The incidence of stroke was thus 11.3 per 100,000 woman-years. On the basis of data from 295 women with stroke who were interviewed and their controls, the odds ratio for ischemic stroke among current users of oral contraceptives, as compared with former users and women who had never used such drugs, was 1.18 (95 percent confidence interval, 0.54 to 2.59) after adjustment for other risk factors for stroke. The adjusted odds ratio for hemorrhagic stroke was 1.14 (95 percent confidence interval, 0.60 to 2.16). With respect to the risk of hemorrhagic stroke, there was a positive interaction between the current use of oral contraceptives and smoking (odds ratio for women with both these factors, 3.64; 95 percent confidence interval, 0.95 to 13.87). Conclusions Stroke is rare among women of childbearing age. Low-estrogen oral-contraceptive preparations do not appear to increase the risk of stroke. (C)1996, Massachusetts Medical Society.
引用
收藏
页码:8 / 15
页数:8
相关论文
共 19 条
[1]  
[Anonymous], 1995, LANCET, V346, P1575
[2]  
DYKEN ML, 1984, STROKE, V15, P1105
[3]   ORAL-CONTRACEPTIVE ESTROGEN DOSE AND THE RISK OF DEEP VENOUS THROMBOEMBOLIC DISEASE [J].
GERSTMAN, BB ;
PIPER, JM ;
TOMITA, DK ;
FERGUSON, WJ ;
STADEL, BV ;
LUNDIN, FE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 133 (01) :32-37
[4]   ORAL CONTRACEPTION AND STROKE - EVIDENCE FROM THE ROYAL-COLLEGE-OF-GENERAL-PRACTITIONERS ORAL CONTRACEPTION STUDY [J].
HANNAFORD, PC ;
CROFT, PR ;
KAY, CR .
STROKE, 1994, 25 (05) :935-942
[5]   INVESTIGATION OF DEATHS FROM PULMONARY CORONARY AND CEREBRAL THROMBOSIS AND EMBOLISM IN WOMEN OF CHILD-BEARING AGE [J].
INMAN, WHW ;
VESSEY, MP .
BRITISH MEDICAL JOURNAL, 1968, 2 (5599) :193-&
[6]   THROMBOEMBOLIC DISEASE AND STEROIDAL CONTENT OF ORAL CONTRACEPTIVES - A REPORT TO COMMITTEE ON SAFETY OF DRUGS [J].
INMAN, WHW ;
VESSEY, MP ;
WESTERHOLM, B ;
ENGELUND, A .
BMJ-BRITISH MEDICAL JOURNAL, 1970, 2 (5703) :203-+
[7]  
JORDAN WM, 1961, LANCET, V2, P1146, DOI DOI 10.1016/S0140-6736(61)91061-3
[8]  
KAY CR, 1982, AM J OBSTET GYNECOL, V142, P762
[9]   ORAL CONTRACEPTION AND RISK OF A CEREBRAL THROMBOEMBOLIC ATTACK - RESULTS OF A CASE-CONTROL STUDY [J].
LIDEGAARD, O .
BRITISH MEDICAL JOURNAL, 1993, 306 (6883) :956-963
[10]   SUBARACHNOID HEMORRHAGE AND HORMONAL FACTORS IN WOMEN - A POPULATION-BASED CASE-CONTROL STUDY [J].
LONGSTRETH, WT ;
NELSON, LM ;
KOEPSELL, TD ;
VANBELLE, G .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (03) :168-173